Understanding how certain genetic changes lead to advanced stomach cancer
Mechanisms of CDH1-inactivated advanced gastric adenocarcinoma tumorigenesis
This study is looking into how a specific gene called CDH1 affects the growth of advanced stomach cancer, with the hope of finding better treatment options tailored to different types of the disease, so that patients can receive care that works best for them.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11052790 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind advanced gastric adenocarcinoma (GAC), particularly focusing on the role of the CDH1 gene in tumor development. By identifying specific subtypes of GAC, the study aims to stratify patients for tailored treatments based on their tumor characteristics. The researchers utilize advanced techniques, including murine organoid models and genetic engineering, to explore how these tumors grow and respond to therapies. The goal is to uncover unique immune profiles and potential therapeutic targets that could improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with advanced gastric adenocarcinoma, particularly those with CDH1 inactivation.
Not a fit: Patients with early-stage gastric cancer or those whose tumors do not involve CDH1 inactivation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective, personalized treatment options for patients with advanced gastric cancer.
How similar studies have performed: Previous research has shown promise in targeting specific genetic alterations in cancer, suggesting that this approach could yield significant insights and advancements.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Zou, Gengyi — University of Tx Md Anderson Can Ctr
- Study coordinator: Zou, Gengyi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.